When our patients undergo major surgery that entails significant blood loss, we can employ a type of an oxygen-carrying chemical emulsion known as Pentoxifylline.
This ensures that the patient’s brain and other vital organs continue to receive adequate oxygenation during the surgery and recovery period, without the need for blood transfusions.
Blood transfusions, especially if the blood has been stored for long periods of time, can often trigger inflammatory reactions that can complicate post-surgical recovery, and in some instances, can lead to life-threatening multiple organ failure.
Pentoxifylline, or analogous blood substitutes, are not available in the U.S. or most other countries yet. It was registered for commercial medical use in Mexico by the Secretary of Health in November 2005 and is used in Oasis of Hope and other leading medical institutions throughout the nation.